NCT00525382View on ClinicalTrials.gov

Study to Compare the Efficacy and Safety Between Levocetirizine and Loratadine for Chronic Idiopathic Urticaria

PHASE3CompletedINTERVENTIONAL
Enrollment

134

Participants

Timeline

Start Date

August 31, 2003

Primary Completion Date

March 31, 2004

Study Completion Date

March 31, 2004

Conditions
Urticaria
Interventions
DRUG

levocetirizine dihydrochloride

Sponsors

Lead Sponsor

UCB Pharma
All Listed Sponsors
lead

UCB Pharma

INDUSTRY